403 related articles for article (PubMed ID: 32349769)
1. O-GlcNAcylation and its role in the immune system.
Chang YH; Weng CL; Lin KI
J Biomed Sci; 2020 Apr; 27(1):57. PubMed ID: 32349769
[TBL] [Abstract][Full Text] [Related]
2. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
[TBL] [Abstract][Full Text] [Related]
3. '
Zhao L; Shah JA; Cai Y; Jin J
Molecules; 2018 Aug; 23(8):. PubMed ID: 30082668
[TBL] [Abstract][Full Text] [Related]
4. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation and neurodegeneration.
Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
[TBL] [Abstract][Full Text] [Related]
6. Functional significance of O-GlcNAc modification in regulating neuronal properties.
Hwang H; Rhim H
Pharmacol Res; 2018 Mar; 129():295-307. PubMed ID: 29223644
[TBL] [Abstract][Full Text] [Related]
7. Too sweet to resist: Control of immune cell function by O-GlcNAcylation.
de Jesus T; Shukla S; Ramakrishnan P
Cell Immunol; 2018 Nov; 333():85-92. PubMed ID: 29887419
[TBL] [Abstract][Full Text] [Related]
8. OGT: a short overview of an enzyme standing out from usual glycosyltransferases.
Aquino-Gil M; Pierce A; Perez-Cervera Y; Zenteno E; Lefebvre T
Biochem Soc Trans; 2017 Apr; 45(2):365-370. PubMed ID: 28408476
[No Abstract] [Full Text] [Related]
9. Undetectable histone O-GlcNAcylation in mammalian cells.
Gagnon J; Daou S; Zamorano N; Iannantuono NV; Hammond-Martel I; Mashtalir N; Bonneil E; Wurtele H; Thibault P; Affar el B
Epigenetics; 2015; 10(8):677-91. PubMed ID: 26075789
[TBL] [Abstract][Full Text] [Related]
10. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
[TBL] [Abstract][Full Text] [Related]
11. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.
Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V
Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803
[TBL] [Abstract][Full Text] [Related]
12. Yeast cells as an assay system for in vivo O-GlcNAc modification.
Nakanishi H; Li F; Han B; Arai S; Gao XD
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver.
Guinez C; Filhoulaud G; Rayah-Benhamed F; Marmier S; Dubuquoy C; Dentin R; Moldes M; Burnol AF; Yang X; Lefebvre T; Girard J; Postic C
Diabetes; 2011 May; 60(5):1399-413. PubMed ID: 21471514
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAc is required for the survival of primed pluripotent stem cells and their reversion to the naïve state.
Miura T; Nishihara S
Biochem Biophys Res Commun; 2016 Nov; 480(4):655-661. PubMed ID: 27983978
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation of RBM14 contributes to elevated cellular O-GlcNAc through regulation of OGA protein stability.
Kweon TH; Jung H; Ko JY; Kang J; Kim W; Kim Y; Kim HB; Yi EC; Ku NO; Cho JW; Yang WH
Cell Rep; 2024 May; 43(5):114163. PubMed ID: 38678556
[TBL] [Abstract][Full Text] [Related]
17. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
[TBL] [Abstract][Full Text] [Related]
18. Sustained
Tan EP; McGreal SR; Graw S; Tessman R; Koppel SJ; Dhakal P; Zhang Z; Machacek M; Zachara NE; Koestler DC; Peterson KR; Thyfault JP; Swerdlow RH; Krishnamurthy P; DiTacchio L; Apte U; Slawson C
J Biol Chem; 2017 Sep; 292(36):14940-14962. PubMed ID: 28739801
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W
Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAc cycling enzymes control vascular development of the placenta by modulating the levels of HIF-1α.
Yang YR; Jang HJ; Lee YH; Kim IS; Lee H; Ryu SH; Suh PG
Placenta; 2015 Oct; 36(10):1063-8. PubMed ID: 26286378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]